News
Resources
Blog
Sites
Jackie McRae is a Director of Policy, Research, and Membership at PhRMA focusing on health equity and the value of medicines. Jackie graduated with a Doctorate of Pharmacy from Mercer University and Master of Science in Applied Health Economics and Outcomes Research from Thomas Jefferson University. Jackie previously worked as a Post-Doctoral Fellow in Health Economics and Outcomes Research at Janssen Scientific Affairs and Thomas Jefferson University. Outside the office, Jackie can be found hiking on local trails and enjoying scenic drives.
Recent Posts
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities
By Jackie McRae | June 16, 2022
A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...
Read More
PhRMA presents research at ISPOR 2022
By Jackie McRae | May 26, 2022
Last week at the ISPOR annual international meeting, PhRMA partnered with multiple organizations committed to advancing value assessment research and methods. We worked with a range of academics,...
Read More
Addressing social determinants of health to improve equitable access to medicines
By Jackie McRae | May 19, 2022
PhRMA Awards $150,000 to Address Social Determinants of Health:Announcing the Recipients of Round 4 of the PhRMA Collaborative Actions to Reach Equity (CAREs) Grant Program As part of PhRMA’s...
Read More
Announcing CAREs Grant Round 4
By Jackie McRae | November 12, 2021
Medicines can be critical to treating, managing, and sometimes curing illnesses, thereby offering an effective tool to improve health outcomes and reduce health disparities. However, numerous studies...
Read More
PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics
By Jackie McRae | September 21, 2021
The COVID-19 pandemic has widened health disparities, including the gap in average life expectancy and outcomes for many chronic diseases. These inequities in health status and outcomes among racial...
Read More
New research shows hotspots of inequity relate to increased COVID-19 hospitalizations
By Jackie McRae | January 8, 2021
As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this summer...
Read More
PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence
By Jackie McRae | November 24, 2020
Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – systemic...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
